drugset / Trial / NCT05640453
Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Timeline
- Start
- 2022-12-15
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.2 ug | — |
| Comparator | Dexmedetomidine | Other / unclassified | 0.7 ug | — |
| Comparator | Pregabalin | Small molecule | 75 mg | Other |